CURRENT ISSUE Current Issue Cover
VOL 5 • NUMBER 4 JUL/AUG
IN THIS ISSUE

Transparency in Medicare Reimbursement: Help or Hindrance?

Wendy H. Vogel, MSN, FNP, AOCNP®

Targeted Therapies in Breast Cancer: Implications for Advanced Oncology Practice

Laura Bourdeanu, PhD, and Thehan Luu, MD

The History and Physical in Cancer Care: A Primer for the Oncology Advanced Practitioner

Margaret Quinn Rosenzweig, PhD, FNP-BC, AOCNP®, Diane Gardner, FNP, MSN, and Brenda Griffith

Approaches to Managing Safety With Lenalidomide in Hematologic Malignancies

Susan Blumel, RN, BSN, and Jackie Broadway-Duren, DNP, APRN, FNP-C

More Articles More Articles
 
Section Seperator

TODAY'S NEWS

Statin Use Associated With Decreased Ris...

Statin use was associated with a significantly red...

New Molecular Test Increases Odds of Cor...

The routine use of a molecular testing panel devel...

Adaptive Intensity-Modulated Radiation T...

A novel, dosimetry-triggered, adaptive intensity-m...

Dutch Phase II Study Supports Phase III ...

Bevacizumab is frequently used in patients with re...

Higher Plasma Vitamin D Concentration As...

In a Scottish study reported in the <em>Jour...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Management of Malignant Pericardial Effusion

The pericardium surrounds the heart...

The Case for Early Palliative Care in Ovarian Cancer

Once referred to as a silent killer...

Vismodegib for Basal Cell Carcinoma

Skin cancer is the most common cancer...

Healthy Weight Loss for the Cancer Survivor

For most oncology patients, weight gain is...

Lessons Learned in Cancer Care Communication

Over the past several decades, outcomes...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Antipain Agent Shrinks Oral Cancers, Spa...

Mouse models of human oral cancer treated with cap...

Combined BRAF V600E and TERT Promoter Mu...

In a study reported in <em>Journal of Clinic...

Study Defines Four Molecular Subtypes of...

Investigators of The Cancer Genome Atlas project h...

FDA Approves Idelalisib for Three Types ...

The U.S. Food and Drug Administration (FDA) today ...

Study Suggests That Primary Androgen-Dep...

Primary androgen-deprivation therapy has been wide...

More Highlights More Highlights
 
Section Seperator
Section Seperator
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer